CNR Institutional Research Information System

Petrosino, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.260
NA - Nord America 824
SA - Sud America 376
EU - Europa 294
AF - Africa 34
OC - Oceania 3
Totale 3.791
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 971
US - Stati Uniti d'America 778
CN - Cina 551
BR - Brasile 310
HK - Hong Kong 235
VN - Vietnam 174
FR - Francia 108
KR - Corea 104
IT - Italia 75
JP - Giappone 67
IN - India 37
NL - Olanda 28
BD - Bangladesh 24
AR - Argentina 22
CA - Canada 22
FI - Finlandia 16
MX - Messico 16
ID - Indonesia 14
IL - Israele 14
GB - Regno Unito 12
EC - Ecuador 11
TR - Turchia 11
PK - Pakistan 10
UA - Ucraina 10
CO - Colombia 9
DE - Germania 9
IQ - Iraq 9
ZA - Sudafrica 9
SA - Arabia Saudita 8
RU - Federazione Russa 7
AT - Austria 6
EG - Egitto 6
MA - Marocco 6
PY - Paraguay 6
UZ - Uzbekistan 6
CL - Cile 5
BG - Bulgaria 4
PE - Perù 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
VE - Venezuela 4
AU - Australia 3
AZ - Azerbaigian 3
JO - Giordania 3
KE - Kenya 3
PL - Polonia 3
AM - Armenia 2
BH - Bahrain 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EE - Estonia 2
ES - Italia 2
GT - Guatemala 2
LK - Sri Lanka 2
LT - Lituania 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
HU - Ungheria 1
IE - Irlanda 1
JM - Giamaica 1
LB - Libano 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
VI - Stati Uniti Isole Vergini 1
YE - Yemen 1
Totale 3.791
Salva come PNG Salva come JPEG
Città #
Singapore 585
Santa Clara 308
Hefei 277
Hong Kong 233
San Jose 115
Seoul 102
Lauterbourg 92
Beijing 61
Ho Chi Minh City 58
Tokyo 50
Ashburn 45
Hanoi 36
São Paulo 28
Dallas 26
Los Angeles 21
New York 17
Minamishinagawa 15
Shenzhen 14
Bengaluru 11
Helsinki 11
Milan 11
Buffalo 10
Guangzhou 9
Naples 9
Rio de Janeiro 9
Haiphong 8
Dhaka 7
Brasília 6
Curitiba 6
Da Nang 6
Lahore 6
Quận Bình Thạnh 6
Rome 6
Asunción 5
Atlanta 5
Biên Hòa 5
Cairo 5
Campinas 5
Istanbul 5
Phoenix 5
Shanghai 5
Boardman 4
Denver 4
Elk Grove Village 4
Jeddah 4
Kyiv 4
Porto Alegre 4
Quito 4
Thái Bình 4
Toronto 4
Amman 3
Baghdad 3
Baku 3
Belo Horizonte 3
Bogotá 3
Bắc Ninh 3
Caxias do Sul 3
Changsha 3
Chongqing 3
Contagem 3
Fortaleza 3
Frankfurt am Main 3
Hòa Bình 3
Itajaí 3
Johannesburg 3
Lấp Vò 3
Montevideo 3
Montreal 3
Orem 3
Philadelphia 3
San Francisco 3
Suzhou 3
São José dos Campos 3
Tashkent 3
Treviso 3
Tunis 3
Vienna 3
Afragola 2
Amsterdam 2
Ankara 2
Aparecida de Goiânia 2
Aracaju 2
Araguari 2
Assago 2
Barra Bonita 2
Betim 2
Bologna 2
Boryspil 2
Bragança Paulista 2
Buenos Aires 2
Bình Dương 2
Calgary 2
Campos dos Goytacazes 2
Can Tho 2
Cape Town 2
Cavallino 2
Charlotte 2
Chennai 2
Colombo 2
Colorado Springs 2
Totale 2.407
Salva come PNG Salva come JPEG
Nome #
Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. 99
Interactions of non-THC phytocannabinoids and Cannabis extracts with TRP channels and endocannabinoid metabolic enzymes 75
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity 71
Analysis of the oral microbiome during hormonal cycle and its alterations in menopausal women: the “AMICA” project 70
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson s disease 69
Endocannabinoid chemical biology: a tool for the development of novel therapies 66
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 65
CB1, but not CB2, mediates stimulation of bone formation induced by traumatic brain injury. 63
Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes 61
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent. 58
Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. 54
1.Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis. 53
Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats 52
N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion 52
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis 51
Tetrahydrolipstatin analogues: new selective pharmacological tools to investigate 2-AG metabolism 50
INSULIN AS A NEGATIVE REGULATOR OF PLASMA ENDOCANNABINOID LEVELS IN OBESE AND NONOBESE SUBJECTS 50
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations 49
Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100 ² up-regulation in vitro 47
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia 47
Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study 47
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. 44
Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis 44
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease 43
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis 43
INVOLVEMENT OF RETINAL PROJECTIONS TO THE LATERAL HYPOTHALAMUS IN LIGHT-MEDIATED ENDOCANNABINOID SYNTHESIS: CRITICAL ROLE OF OREXINERGIC AND ENDOCANNABINOID SYSTEMS IN LIGHT-ENTRAINABLE RHYTHMS 42
Exposure to allergen causes changes in nts neural activities after intratracheal capsaicin application, in endocannabinoid levels and in the glia morphology of nts 41
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. 40
Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. 39
Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain 39
Protective role of palmitoylethanolamide in contact allergic dermatitis 36
Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets 36
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties 36
LIVER AND ADIPOSE TISSUE ENDOCANNABINOID TONE IN DIET-INDUCEDOBESITY IS DEPENDENT ON APOLIPOPROTEIN E EXPRESSION ANDASSOCIATED WITH HEPATIC STEATOSIS AND INSULIN RESISTANCE 35
The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels 35
From endocannabinoid profiling to 'endocannabinoid therapeutics' 34
The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption 34
FULL INHIBITION OF SPINAL FATTY ACID AMIDE HYDROLASE IN NEUROPATHIC RATS LEADS TO TRPV1-MEDIATED ANALGESIC EFFECTS VIA REMODELING OF THE ENDOCANNABINOID SYSTEM 34
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels. 34
European Biotech Week 2020-"L'ETERNA LOTTA TRA L'UOMO E IL VIRUS". 33
Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels 33
FAAH inhibition elevates endocannabinoid levels in the periaqueductal grey of the rat: dual effect on nociception via CB1 and TRPV1 receptors 32
Effect of N-arachidonoylserotonin (AA-5-HT), a FAAH inhibitor with antagonistic activity at vanilloid TRPV1 receptor, in an animal model of acute inflammation. 32
The endocannabinoid system is modulated in response to spinal cord injury in rats. 32
The levels of the endocannabinoid receptor CB2 and its ligand 2-Arachidonoylglycerol are elevated in endometrial carcinoma. 30
Neonatal stress-induced neurodegeneration: a suitable animal model to evaluate neuroprotective and modulatory properties of cannabinoids. 30
Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: A possible role for the endocannabinoid system. 29
Protective role of palmitoylethanolamide in keratinocytes and its involvement in contact allergic dermatitis. 29
Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide 29
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration 29
Effect of inhibitors of endocannabinoid uptake and FAAH on brain endocannabinoid levels. 28
Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: insulin and melanocortins 28
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 28
An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis 28
Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation 28
Protective role of aliamides and endocannabinoid system during »-carrageenin-induced granuloma formation. 27
Impaired endocannabinoid levels in selected brain areas of transgenic R6/2 mice, and experimental model of Huntington s disease. 27
Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. 27
Endocannabinoids Are Endogenously Overproduced In Highly Malignant Ovarian Carcinoma: Possible Involvement Of Cox-2 In Their Tonic Control Of Cancer Spreading And Potential Pharmacological Relevancies 26
Overactivation of the endocannabinoid system in human endometrial carcinoma. 26
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-fos expression in the hypothalamus 26
Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis. 26
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-induced atrophy in rats 26
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and Ò-cells 26
Alteration of the endocannabinoid system in mouse brain during prion disease. 26
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes 26
Alterations in endocnnabinoid levels accompanying parkinsonism and levodopa-induced dyskinesia in the MPTP-lesioned macaque 26
Fatty acid amide hydrolase controls mouse intestinal motility in vivo 26
The endocannabinoid system is activated in response to spinal cord injury in rats. 25
The chemotherapeutic agent cisplatin increases brain 2-arachidonoyl-glycerol (2-AG) concentrations and concomitantly reduces intestinal 2-AG and anandamide levels in a vomiting species (the least shrew). 25
Attenuation of allergic contact dermatitis through the endocannabinoid system 25
Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish 25
Direct and indirect modulation of cannabinoid system in a phencyclidine model of schizophrenia 25
Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease 25
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities. 25
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. 25
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 25
Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice 24
Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. 24
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine. 23
The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats. 23
Attenuation of allergic contact dermatitis through the endocannabinoid system. 22
ANANDAMIDE INJECTED INTRATHECALLY INDUCES ANALGESIA MEDIATED BY A TRPV1-DEPENDENT MECHANISM IN NEUROPATHIC RATS 22
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men 22
CB2 receptors in mouse male germ cell differentiation 22
Endocannabinoid and orexin-1 interactions in the hypothalamus: one possibile clue to obesity 22
The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 22
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling 22
Possible Anandamide and Palmitoylethanolamide involvement in human stroke. 22
POTENTIAL OXIDATION OF 2-AG BY COX-2 ENHANCES MALONATE TOXICITY IN THE STRIATUM: RELEVANCE FOR CANNABINOID TREATMENTS IN HUNTINGTON S DISEASE 22
Increased skin levels of the aliamide palmitoylethanolamide and endogenous fatty acid amides in dogs with atopic dermatitis. 22
Regulation, function and dysregulation of endocannabinoids in models of adipose and b-pancreatic cells and in obesity and hyperglycemia 21
ALTERATIONS OF BASAL AND FASTING/REFEEDING-REGULATED TISSUE LEVELS OF ENDOGENOUS N-ACYL-ETHANOLAMINE LIGANDS OF PPAR-± ESE ZUCKER RATS 21
Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both CB1 and TRPV1 receptors 21
The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice. 21
Alterations of endocannabinoid and acylethanolamide levels in peripheral tissues of mice on a high fat diet: implications for gastric emptying and metabolism. 21
Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors 21
POSSIBLE ENTOURAGE EFFECT OF PALMITOYLETHANOLAMIDE IN DOG AND HUMAN PLASMA 21
ACTIVATION OF SPINAL TRPV1 OR CB1 RECEPTORS IN NEUROPATHIC RATS DEPENDS ON ANANDAMIDE CONCENTRATION 20
LEPTIN-CONTROLLED OREXIN/ENDOCANNABINOID INTERACTIONS IN THE MOUSE PERIAQUEDUCTAL GREY: ROLE IN THE REGULATION OF THE DESCENDING ANTINOCICEPTIVE PATHWAY 20
Totale 3.483
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.644
article - articoli 9.494
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.138
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202419 0 0 0 0 0 0 0 0 4 0 10 5
2024/20251.427 5 11 148 65 302 21 7 88 23 35 376 346
2025/20262.349 126 272 245 419 382 69 367 126 159 101 63 20
Totale 3.795